ORMP
ORMP
US68403P2039
Oramed Pharmaceuticals Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 2.000.000 --
--
Cost of Revenue 1.987.000 --
--
Gross Profit 13.000 --
--
15.101.000 12.781.000
18.2%
Operating Income -15.088.000 -12.781.000
18.1%
Pretax Income 75.324.000 -15.920.000
573.1%
Net Income Common Stockholders 64.050.000 -19.060.000
436.0%
-- --
--
-- --
--
ende